Sumitomo Chemical India Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/e80izwecxerx1rehi5kmprga.pdf

Key Takeaways


Profitability & Margin Dynamics

Chetan Shah: "I don't think personally that input cost is going to go up significantly. And I don't think that the prices of products in the end-market is going to fall drastically. So it's a very healthy, balanced situation that we are in today."

Domestic Demand: Volume Resilience, Price Pain

Chetan Shah: "We say that we are still haunted by rabi season figures always been lower than kharif. So we need to be mindful of that. Because the companies or the competition will behave a little differently in rabi season."

Export Recovery

Kunal Mittal: "I think what Shah san commented gives a good comprehensive picture of the total business, both domestic and exports, and it was not like a few particular exports order of higher margin. This was comprehensive growth in the business, and it should be read that way."

New Products & Portfolio Evolution

Kunal Mittal: "If we get at least a 20% – 25% growth on these molecules or these brands year-on-year, I think that itself is a very decent growth."

Capex & Capacity Expansion

Chetan Shah: "I'm happy to inform you that, yes, last month, or during this month, we received the EC clearance without any specific conditions. And it is whatever was our application, we got clearance on all our products."

Strategic Initiatives & Market Positioning


Guidance & Commitments

CommitmentSpecificsTimeline
Full-year domestic revenue growth~9-10% (revised from 10-15%)FY25
Full-year EBITDA margin18-20% rangeFY25
New product/molecule growthAt least 20-25% YoYAnnual, ongoing
Dahej Phase 1 construction startBeginning in 20262026
Dahej Phase 1 capex cycle2-3 years for Phase 1From construction start
Dahej asset turn at maturity2x capex size2-3 years post-construction for full ramp-up
Tarapur full productionShifted to FY26FY26
Bhavnagar plant 1 full revenueCurrent financial yearFY25
Bhavnagar plant 2 growthGrowth next year over current yearFY26
Export growth vs domesticExport growth percentage higher than domestic (lower base)FY25

Key Metrics

MetricQ2 FY25
Revenue₹995 cr, up 9% YoY and 18% QoQ
Gross margin42.6%, up 421 bps YoY and 365 bps QoQ
EBITDA₹245 cr, up 31% YoY and 52% QoQ
EBITDA margin24.8%, up 402 bps YoY
Profit after tax₹193 cr, up 34% YoY and 52% QoQ
PAT margin19.5%, up 360 bps YoY
H1 revenue₹1,827 cr, up 12% YoY
H1 EBITDA margin22.2%, up from 16.5% in H1 FY24
H1 PAT₹319 cr, up 56% YoY
Domestic volume growth (Q2)~12%, offsetting a 15% average price decline
H1 volume growth15% to 16%
Export share of revenue (H1)17%, up from 11% in H1 FY24
New product sales growth (H1)65% YoY, contributing 8% to 9% of revenue
H1 export growth to South America167% YoY
H1 export growth to Japan122% YoY
Inventory days96 days, flat YoY with inventory at ~₹565 cr